Bringspring Science and Tech (300290) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bringspring Science and Tech (300290) has a cash flow conversion efficiency ratio of 0.015x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.54 Million ≈ $1.83 Million USD) by net assets (CN¥864.05 Million ≈ $126.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bringspring Science and Tech (300290) market capitalisation for the company's overall valuation and market capitalisation.
Bringspring Science and Tech - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Bringspring Science and Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bringspring Science and Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bringspring Science and Tech ranked by their cash flow conversion efficiency. Explore 300290 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Legacy Housing Corp
NASDAQ:LEGH
|
0.043x |
|
Hunan Huamin Holdings Co Ltd
SHE:300345
|
-0.046x |
|
Beijing Vastdata Technology Co Ltd
SHG:603138
|
-0.015x |
|
indie Semiconductor Inc
NASDAQ:INDI
|
-0.090x |
|
Hunan Fangsheng Pharm Co Ltd
SHG:603998
|
0.052x |
|
Tronox Holdings PLC
NYSE:TROX
|
0.084x |
|
COPLAND ROAD CAPITAL NEW
F:A2P
|
0.295x |
|
Yesway, Inc. Class A Common Stock
NASDAQ:YSWY
|
0.123x |
Annual Cash Flow Conversion Efficiency for Bringspring Science and Tech (2009–2025)
The table below shows the annual cash flow conversion efficiency of Bringspring Science and Tech from 2009 to 2025. View latest Bringspring Science and Tech stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥830.91 Million ≈ $121.59 Million |
CN¥-47.12 Million ≈ $-6.89 Million |
-0.057x | -103.72% |
| 2024-12-31 | CN¥897.21 Million ≈ $131.29 Million |
CN¥-24.97 Million ≈ $-3.65 Million |
-0.028x | -146.41% |
| 2023-12-31 | CN¥887.03 Million ≈ $129.80 Million |
CN¥53.21 Million ≈ $7.79 Million |
0.060x | +118.99% |
| 2022-12-31 | CN¥861.22 Million ≈ $126.02 Million |
CN¥23.59 Million ≈ $3.45 Million |
0.027x | +6421.76% |
| 2021-12-31 | CN¥1.08 Billion ≈ $158.57 Million |
CN¥455.13K ≈ $66.60K |
0.000x | -99.48% |
| 2020-12-31 | CN¥1.41 Billion ≈ $206.43 Million |
CN¥113.83 Million ≈ $16.66 Million |
0.081x | +10.16% |
| 2019-12-31 | CN¥1.10 Billion ≈ $160.42 Million |
CN¥80.30 Million ≈ $11.75 Million |
0.073x | -31.44% |
| 2018-12-31 | CN¥889.94 Million ≈ $130.23 Million |
CN¥95.09 Million ≈ $13.91 Million |
0.107x | +306.03% |
| 2017-12-31 | CN¥709.65 Million ≈ $103.84 Million |
CN¥18.67 Million ≈ $2.73 Million |
0.026x | -51.76% |
| 2016-12-31 | CN¥904.36 Million ≈ $132.34 Million |
CN¥49.34 Million ≈ $7.22 Million |
0.055x | -9.91% |
| 2015-12-31 | CN¥874.76 Million ≈ $128.01 Million |
CN¥52.97 Million ≈ $7.75 Million |
0.061x | -31.95% |
| 2012-12-31 | CN¥345.00 Million ≈ $50.49 Million |
CN¥30.70 Million ≈ $4.49 Million |
0.089x | -73.66% |
| 2011-12-31 | CN¥146.23 Million ≈ $21.40 Million |
CN¥49.41 Million ≈ $7.23 Million |
0.338x | -16.10% |
| 2010-12-31 | CN¥101.38 Million ≈ $14.83 Million |
CN¥40.82 Million ≈ $5.97 Million |
0.403x | +1.87% |
| 2009-12-31 | CN¥33.42 Million ≈ $4.89 Million |
CN¥13.21 Million ≈ $1.93 Million |
0.395x | -- |
About Bringspring Science and Tech
Bringspring Science and Technology Co., Ltd. engages in the smart healthcare business in China. It operates through Health Care and Social Security, Government and Public Utilities, and Others segments. The company offers medical record statistics, medical record tracing, digital medical records, and paperless medical record management; smart healthcare solutions for core clinical scenarios; and … Read more